Coronary artery bypass grafting is the most common cardiac surgery operation performed worldwide. It is the most effective revascularization method for several categories of patients affected by coronary artery disease. Although coronary artery bypass grafting has been performed for more than 40 years, no detailed guidelines on the choice of coronary artery bypass grafting conduits have been published and the choice of the revascularization strategy remains more a matter of art than of science. Moreover, there is a clear contradiction between the proven benefits of arterial grafting and its very limited use in everyday clinical practice. In the hope of encouraging wider diffusion of arterial revascularization and to provide a guide for clinicians, we discuss current evidence for the use of different conduits in coronary artery bypass surgery and propose an evidence-based algorithm for the choice of the second conduit during coronary artery 
With the aim of encouraging a wider diffusion of arterial revascularization, and to provide a guide for clinicians, we herein discuss the current evidence basis for the use of different arterial conduits for CABG and propose an evidence-based algorithm for the choice of the second conduit during coronary operations.
SEARCH METHOD
In December 2014, the PubMed database was searched using the terms "radial artery," "gastroepiploic artery," and "internal thoracic artery" coupled with "coronary surgery," "myocardial revascularization," "coronary artery bypass," "CABG," and "patency."
Relevant abstracts were reviewed and the related articles function was used for all included manuscripts. References for all selected studies were crosschecked. The present review focuses on data from randomized controlled trials (RCT), propensitymatched observational series, and meta-analyses.
Unmatched observational series were considered only when data from RCT or propensity-matched studies were not available.
It is important to note that the quality and weight of the evidence for the various conduits is not the same. RCT and propensity-matched series include around 25,000 patients for bilateral internal thoracic arteries (BITA), 2,000 for the radial artery (RA), and a few hundred for the right gastroepiploic artery (GEA).
BILATERAL INTERNAL THORACIC ARTERIES
The survival benefits associated with the use of the left internal thoracic artery (ITA) to the left anterior descending (LAD) coronary artery were established in a landmark paper from the Cleveland Clinic almost 30 years ago (1) . The improved outcome using the ITA is almost certainly due to its superior long- Mortality, stroke, myocardial infarction, and repeat revascularization were all under 2.5% (5).
While awaiting the outcome of the ART trial, there is currently a substantial body of circumstantial evidence to support the use of a second ITA, as it appears to offer an additional survival benefit over a single ITA graft. Indeed, more than a decade ago, a systematic review of matched cohorts of almost 15,000 CABG patients who received BITA grafts reported a significant reduction in the hazard ratio (HR) for mortality of 0.78 (6) . In the past 2 years, 2 independent meta-analyses have supported this finding, not only in larger cohorts of patients, but also with (9) . This risk is even higher in diabetics and in patients with pulmonary disease (9) . In ART, the incidence of sternal wound complications increased from 0.6% in the single ITA group to 1.9% in the BITA group (i.e., an absolute difference of 1.3% or a number needed to harm of 78 patients) (5).
However, the incidence of serious wound problems can be significantly reduced by judicious patient selection and the choice of harvesting technique.
Consideration should be given to avoiding BITA in patients with certain potentially morbid characteristics, especially if they occur simultaneously (diabetes, obesity, respiratory problems), and in patients receiving steroids or immunosuppression treatments. Moreover, 2 systematic reviews have both reported that skeletonization, rather than a pedicled harvesting technique, significantly reduces deep sternal wound infections, even in patients with diabetes (9, 10) . Importantly, the survival benefit of BITA grafting is seen in both nondiabetic and diabetic patients (11) .
THE RADIAL ARTERY
Introduced in coronary surgery in the 1970s (12), the RA was "rediscovered" in the early 1990s (13). Con- Gaudino et al.
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such therapy is still widely adopted in the surgical community (16) .
The largest angiographic series report an RA patency rate of 80% to 90% at 7 to 10 years follow-up (17) . The severity of the stenosis of the target vessel is a key factor in determining RA patency. There is general agreement that the RA should be used only to bypass a vessel with >70% stenosis, and there is evidence that a 90% stenosis limit ensures an even better RA patency rate, especially on the right coronary system (18, 19) . The site of proximal anastomosis and the harvesting technique (open vs. endoscopic) do not affect RA patency rates, whereas there is some evidence that skeletonization of the artery can lead to better perfect patency rates (20) .
The RA is the arterial conduit for which there is the most evidence derived from RCT. In fact, 4 RCT have compared the RA with either SVG or the right internal thoracic artery (RITA) (18,21-23) ( Table 1 ). All studies that extended the follow-up beyond the first postoperative year showed significantly better patency rates for the RA over the SVG, and in 2 studies, a tendency toward a lower incidence of clinical events was also found for RA patients.
A number of meta-analyses pooled data from these RCT and large observational studies to compare the RA and the SVG (24) (25) (26) (27) (28) (29) . Again, all studies with a mean follow-up time extending beyond the first postoperative year reported significant benefits in terms of graft patency for the RA ( Table 2 CI ¼ confidence interval; OR ¼ odds ratio; other abbreviations as in Table 1 .
Choice of Conduits for CABG evidence is available regarding the comparison between the RA and the GEA (Table 3 ) (36,37). Two recent series reported that use of the GEA, instead of the SV, to graft the right coronary artery in patients having BITA to the left coronary system leads to a significant increase in late survival (48, 49) . The increased patency rate in case of skeletonized grafts and subocclusive target vessel stenosis is evident. GEA ¼ gastroepiploic artery. 
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However, other studies have not confirmed this finding, and a recent network meta-analysis of RCT comparing all conduits used in coronary surgery found the GEA to be associated with the highest risk of functional and complete graft occlusion (29) . Of note, a major bias in the current literature is that the majority of published series report use of the GEA as a pedicled, rather than as a skeletonized graft; skeletonized harvest of the artery has been shown to significantly improve its patency (47) . Very few studies have compared the GEA with the RITA (Table 3 
